Lisa Berman-Booty VMD, PhD, DACVP
Dr. Lisa Berman-Booty earned undergraduate (BA [summa cum laude], 2004) and veterinary medical (VMD [summa cum laude], 2008) degrees at the University of Pennsylvania. She then attended The Ohio State University, completing an anatomic pathology residency and board certification as a Diplomate of the American College of Veterinary Pathologists (ACVP, 2012) while earning a PhD in Comparative and Veterinary Medicine (2013). Her doctoral dissertation, with its focus on evaluating the efficacy and toxicity of a novel small molecule chemotherapeutic agent, allowed Lisa to gain important experience and insight into the early drug discovery process. After returning to Pennsylvania, Lisa spent a year (2013-2014) in academia (at the Kimmel Cancer Center at Thomas Jefferson University) as a comparative pathologist exploring her own hypotheses in cancer biology as well as providing collaborative pathology and mouse phenotyping support to members of the Kimmel Cancer Center. She moved to the pharmaceutical industry, joining Bristol-Myers Squibb (2014-2018) as a principal veterinary pathologist in the Department of Discovery Toxicology. Her primary function at Bristol-Myers Squibb was to design and perform toxicologic pathology evaluations to support discovery research projects, but a major secondary role was phenotypic analysis of the novel genetically engineered mouse disease models. Family events in 2018 dictated that Lisa transition to home-based experimental pathology consulting. Lisa is an active member of the ACVP and the Society of Toxicologic Pathology (STP), having served as a member of the editorial board of the latter’s journal Toxicologic Pathology from 2014-2019. Lisa joined SVP in 2021 as a comparative and toxicologic pathologist and is excited to offer clients her unique combination of discovery toxicology, research pathology, and mouse phenotyping experience and expertise.